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 █ Abstract
Objective: To review recent evidence on child and adolescent depression. Method: Narrative review. Results: Rates of 
unipolar depression are low before puberty, but rise from the early teens, especially among girls. Concurrent comorbidity 
with both disruptive and emotional disorders is common, especially among younger children; across age, youth depression 
may be preceded by both anxiety and disruptive behaviour disorders, and increase risk for alcohol problems. Adolescent 
depression is associated with a range of adverse later outcomes including suicidality, problems in social functioning 
and poor physical and mental health. Across development, a family history of depression and exposure to stressful life 
events are the most robust risk factors for depression. Familial transmission involves both psychosocial and heritable 
processes; genetic and environmental influences also combine to influence risk. Neurocognitive and neuroendocrine 
pathways have been established, but contributors to the adolescent rise in risk, and the female preponderance later in 
development, remain to be clarified. Depressed youth benefit from psychological therapy or antidepressant medication or 
their combination; however, treatment effects are moderate. Conclusions: Despite considerable progress in understanding 
developmental trajectories to depression, more needs to be done to identify disease mechanisms that may serve as 
intervention targets early in the life course.
Key words: aetiology, epidemiology, anti-depressant, depression, adolescence
 █ Résumé
Objectif: Examiner les données probantes récentes sur la dépression chez les enfants et les adolescents.  
Méthode: Revue narrative. Résultats: Les taux de dépression unipolaire sont faibles avant la puberté, mais s’accroissent 
à compter du début de l’adolescence, surtout chez les filles. La comorbidité concurrente avec des troubles perturbateurs 
et émotionnels est fréquente, en particulier chez les jeunes enfants; pour tous les groupes d’âge, la dépression 
chez les jeunes peut être précédée d’anxiété et de troubles de comportement perturbateur, et d’un risque accru de 
problèmes d’alcool. La dépression adolescente est associée à une série de résultats ultérieurs indésirables, notamment 
la suicidabilité, des problèmes de fonctionnement social et une mauvaise santé physique et mentale. Durant le 
développement, des antécédents familiaux de dépression et d’exposition à des événements stressants de la vie constituent 
les facteurs de risque les plus marqués pour la dépression. La transmission familiale fait appel à des processus tant 
psychosociaux qu’héréditaires; les influences génétiques et environnementales se combinent également pour influencer 
le risque. Les trajectoires neurocognitives et neuroendocriniennes ont été établies, mais les contributeurs à la hausse 
du risque chez les adolescents, et la prépondérance féminine ultérieure dans le développement ne sont pas encore bien 
définis. Les adolescents déprimés bénéficient de la thérapie psychologique ou des antidépresseurs ou d’une combinaison 
des deux; cependant, les effets du traitement sont modérés. Conclusions: Malgré que notre compréhension des 
trajectoires développementales de la dépression ait fait des progrès considérables, il faut faire davantage pour identifier les 
mécanismes de la maladie qui peuvent servir de cibles aux interventions en début de cours de la maladie.
Mots clés: étiologie, épidémiologie, antidépresseur, dépression, adolescence
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Less than three decades ago depression was seen as a predominantly adult disorder: children were consid-
ered too developmentally immature to experience depres-
sive disorders, and adolescent low mood was seen as part 
of ‘normal’ teenage mood swings. Developmental studies 
have been central in modifying that view. Few would now 
doubt the reality of child and adolescent depressive disor-
ders, or that youth depression is associated with a range of 
adverse outcomes including social and educational impair-
ments as well as both physical and mental health problems 
later in life (see Thapar, Collishaw, Pine, & Thapar, 2012). 
In addition, however, while research on the course and 
correlates of depression has identified important similari-
ties across development, it has also highlighted age-related 
variations; as a result, investigators continue to evaluate the 
extent to which childhood, adolescent and adult onset de-
pressions reflect the same underlying condition (Kaufman, 
Martin, King, & Charney, 2001). This review provides a 
brief introduction to recent evidence in these areas, focus-
ing in particular on: 
  i) descriptive aspects of depressive disorders in  
childhood and adolescence; 
 ii) current understandings of risk processes and  
mechanisms; and, 
iii) evidence-based treatments for depressive disorders  
in youth.
Clinical features and epidemiology
Diagnostic criteria for unipolar depression centre on core 
symptoms of persistent and pervasive sadness, along with 
a loss of interest or pleasure in activities; associated symp-
toms include low self-esteem, excessive guilt, suicidal 
thoughts or behaviours, sleep and appetite disturbances, 
and psychomotor agitation or retardation. In the main, these 
criteria are applied independent of age (including, with age-
appropriate modifications, in recent studies of pre-school-
ers; Luby, 2010). In the DSM-IV criterion set, however, 
marked irritability is allowed as the cardinal mood symp-
tom for children and young people only.
Past-year estimates of the prevalence of major depressive 
disorders in early adulthood range from 10%-17% (Moffitt 
et al., 2010), with women about twice as likely to be af-
fected as men. Earlier in development rates are much lower, 
and show a distinct age- and gender-related profile. Depres-
sion is relatively uncommon in pre-pubertal children (1-
2%), and rates differ little between boys and girls (Egger & 
Angold, 2006). Levels then begin to rise in the early teens, 
more sharply in girls than in boys. As a result, by the mid-
teens the median 12-month prevalence of unipolar depres-
sion is in the region of 4-5%, and the female preponderance 
characteristic of adult depression is clearly established (see 
Thapar et al., 2012).
Throughout the life course depression is comorbid with oth-
er psychiatric disorders. In adulthood, the most prominent 
associations are with anxiety. In school-aged samples (see 
e.g. Ford, Goodman, & Meltzer, 2003) around two-thirds 
of young people with depression show at least one comor-
bid disorder, and over 10% show two or more; overlaps 
with disruptive disorders (Attention Deficit Hyperactivity 
Disorder [ADHD], Oppositional Defiant Disorder [ODD], 
and Conduct Disorder [CD]) are as common as with other 
emotional diagnoses at this stage. In pre-school samples 
rates of comorbidity are even higher, with three in every 
four depressed preschoolers reported as showing other 
vulnerabilities (Egger & Angold, 2006; Wichstrom, Berg-
Nielsen, Angold, Egger, Solheim, & Sveen, 2012). When 
multiple disorders co-occur in this way, some two-way as-
sociations may primarily reflect overlaps among associated 
disorders. ADHD-depression comorbidity seems primarily 
of this kind, mediated by the strong links of both disorders 
with ODD/CD. ODD also appears to play a key role in pre-
school samples; it is the most common concomitant of de-
pression in very young children, and mediates links with 
both ADHD and anxiety at this stage. As Egger and Angold 
(2006) note, these findings raise queries over the extent 
to which depressive disorders in preschoolers are indeed 
equivalent to those seen later in development, or whether 
instead they may index a more global syndrome of emo-
tional and behavioural dysregulation.
Continuities and discontinuities 
across development
Clinical studies of youth depression confirm that it is a 
chronic and recurrent condition: although most episodes re-
mit within a year, the risk of recurrence in clinical samples 
is high, with 50-70% likely to develop a further episode 
within five years (see e.g. Dunn & Goodyer, 2006). Follow-
ups of epidemiological samples - where many cases will be 
less severe - also highlight poor outcomes, with implica-
tions for young people’s social functioning as well as for 
their later mental health. In addition to their public health 
significance, findings of this kind can be informative in ae-
tiological terms. Evidence of homotypic continuities (the 
persistence of the same disorder over time), for example, 
is suggestive of a single disease process manifesting itself 
robustly at different stages of development. Heterotypic 
continuities, by contrast, may suggest either that the same 
underlying disease process manifests differently across de-
velopment, or that one disorder (or its associated impair-
ments) functions as a risk factor for another. Evidence for 
both of these processes has been found for child and ado-
lescent depression.
Beginning with homotypic continuities, follow-ups of 
pre-school samples provide evidence of continued risk 
for depression at least into the early school years (Luby, 
2010). Later in development the picture is more complex. 
First, while most follow-ups of adolescent depression find 
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increased risks of depression and suicidality in adulthood, 
these links are strongly attenuated in multivariate analyses 
that take account of the effects of comorbid disorders such 
as ODD (see e.g. Copeland, Shanahan, Costello, & Angold, 
2009). Second, though few studies have yet examined adult 
outcomes of childhood depression, those that have done so 
(see e.g. Harrington, Fudge, Rutter, Pickles, & Hill, 1990; 
Copeland et al., 2009) have found little or no increased 
risk of depression in adult life. If replicated, these findings 
provide further pointers to the possibility that childhood 
depression differs in important ways from its later onset 
counterparts.
Turning to heterotypic continuities, links with three other 
disorder groupings (anxiety disorders, alcohol and sub-
stance use and CD/ODD) have attracted particular inter-
est. Associations between depression and anxiety are high 
throughout the life course, but their order of emergence ap-
pears to vary systematically across development. Between 
childhood and early adolescence anxiety typically precedes 
depression (Wittchen, Kessler, Pfister, & Lieb, 2000). From 
later adolescence onwards, however, the temporal sequence 
runs in both directions: anxiety predicts depression, but 
depressive disorders also predict later anxiety (Moffitt et 
al., 2007). While these associations seem likely to reflect 
varying expressions of the same underlying liability, oth-
er heterotypic continuities may be better conceptualized 
as psychopathological progressions, whereby one disor-
der contributes, directly or indirectly, to risk for another. 
In relation to alcohol use, for example, though findings 
are complex, commentators are now arguing for a distinct 
internalizing pathway to alcohol use disorders, with self-
medication a central intervening mechanism (Hussong, 
Jones, Stein, Baucom, & Boeding, 2011). Finally, a vari-
ety of processes may underlie the strong risk for depres-
sive disorders associated with prior antisocial behaviour 
and conduct problems. In part, associations of this kind 
may reflect environmentally-mediated effects of selection 
into stress-prone environments. In addition, recent evidence 
points to a specific increased risk for depression associated 
with an irritable sub-component of ODD that shares genetic 
associations with depression (Stringaris, Zavos, Leibenluft, 
Maughan, & Eley, 2012).
Risk processes and mechanisms
Depression is a complex disorder, and a variety of risk fac-
tors and causal pathways are likely to be involved. Evi-
dence for both inherited and psychosocial risks has been 
established for many years; more proximal neurocognitive 
and neuroendocrine mechanisms are now also beginning to 
be better understood. A full consideration of the aetiology 
of depression is beyond the scope of this paper; instead, we 
highlight ways in which a developmental perspective can 
help clarify understanding of causal mechanisms.
Across development, studies of adults, adolescents, chil-
dren and pre-schoolers all point to a family history of de-
pression and exposure to stressful life events as the most 
robust risk factors for depression. Depression runs in fami-
lies, with three-to-four fold elevated rates in the offspring of 
depressed parents. Inherited factors partly account for these 
effects, although genome wide association studies have yet 
to identify replicated gene variants associated with depres-
sion (Thapar et al., 2012). In addition, genetically informa-
tive studies suggest that psychosocial mechanisms are also 
implicated in familial transmission, with adoption studies, 
for example, showing an excess risk of depression in the 
offspring of depressed mothers even in biologically unre-
lated mother-child pairs (Tully, Iacono, & McGue, 2008).
Psychosocial risks include family bereavement, separa-
tions and conflict, child maltreatment and neglect, and peer 
conflict and bullying (see e.g. Jaffee et al., 2002; Kendler, 
Thornton, & Gardner, 2000). Chronic stressors affecting 
relationships appear to have a greater impact than isolated 
acute events, especially in females (Thapar et al., 2012). In 
addition, there are pointers to aetiological differences be-
tween child-, adolescent-, and adult-onset depression. First, 
the balance of inherited and environmental risks appears to 
vary across development, with twin studies consistently re-
porting lower heritability estimates for depression in child-
hood than in adolescence (Thapar & Rice, 2006). Second, 
it has been suggested that juvenile- and adult-onset depres-
sion show different psychosocial risk profiles, with juvenile 
onset more strongly associated with childhood family ad-
versity, parental neglect, and problematic peer relationships 
(Jaffee et al., 2002; Hill, Pickles, Rollinson, Davies, & By-
att, 2004). These studies did not distinguish pre- and post-
pubertal onset within the ‘juvenile’ onset group. One that 
has, however, suggests that such findings reflect recency of 
risk exposure, and that concurrently-assessed stressors are 
on the whole equally strongly associated with child-, ado-
lescent- and adult-onset depression (Shanahan, Copeland, 
Costello, & Angold, 2011). In addition, individual level 
data suggest a diminishing role of stressful events in trig-
gering the onset of successive depressive episodes (Kendler 
et al., 2000). Finally, childhood adversities including pov-
erty, sexual abuse and psychopathology may also present 
distal risks for depression later in the life course (Hill et al., 
2004; Shanahan et al., 2011) via selection into more disad-
vantaged and stressful life circumstances.
Research on gene-environment interplay suggests that 
genes and environments combine to influence vulnerabil-
ity, with heritable factors increasing risk of both exposure 
to stressful environments (gene-environment correlation, 
Lau & Eley, 2008), and susceptibility to psychosocial stress 
(gene-environment interaction, Caspi et al., 2003; Uher 
& McGuffin, 2010). The serotonin transporter gene vari-
ant 5-HTTLPR has received the greatest attention here, 
with evidence that one variant of the gene increases risk 
for depression in those exposed to stressful life events or 
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childhood maltreatment (Caspi et al., 2003). Animal and 
experimental neuroscience evidence supports the biologi-
cal plausibility of gene-environment interactions such as 
this (Rutter, Thapar, & Pickles, 2009). Not all findings are 
consistent, however; in part, this may reflect variations in 
gene-environment interactions by age and/or gender, with, 
for example, more robust evidence in post-pubertal females 
(Uher & McGuffin, 2010). There is also evidence from 
animal models and post mortem brain tissue of depressed 
humans (Schroeder, Krebs, Bleich, & Frieling, 2010) that 
epigenetic alterations in gene expression are implicated 
in depression; developmental studies are required to track 
such epigenetic influences across the life span.
Specific neurocognitive and neuroendocrine pathways in-
volved in the development of depression have also begun to 
be identified. As outlined in a recent review (Thapar et al., 
2012), these pathways are regulated by activity in neural 
circuits involved in the processing of threats and rewards. 
In both instances the circuits involved have been linked to 
risk for depression in evidence from animal research, hu-
man imaging and pharmacological studies. The first circuit 
- involved in processing of threat - connects the amygdala, 
hippocampus and prefrontal cortical regions and is associ-
ated with HPA axis activity. The second, ‘reward’, circuit 
connects the striatum, prefrontal cortex and ventral dopa-
mine-based systems. Both circuits continue to mature and 
show emergent sex differences in adolescence (Forbes & 
Dahl, 2005; Thapar et al., 2012).
From a developmental perspective a key issue concerns 
factors that contribute to the post-pubertal rise and emer-
gent sex difference in depression in adolescence. A variety 
of mechanisms has been proposed here, including gender 
differences in cognitive processing of stressful events and 
coping styles: greater exposure or sensitivity to psychoso-
cial stress in adolescent girls; hormonal changes associated 
with pubertal maturation; and, changes in underlying brain 
development (Angold, Costello, Erkanli, & Worthman, 
1999; Hyde, Mezulis, & Abramson, 2008). Disentangling 
particular causal mechanisms is difficult given the extent 
of cognitive, psychosocial and biological change occurring 
in adolescence, and the likelihood of complex interactions 
between different factors and mechanisms. More evidence 
is also needed on how far the aetiological mechanisms dis-
cussed here are specific to depression or instead contribute 
to broad risk for psychopathology, and may thus help ac-
count for comorbidity.
Treatment and prevention of 
depression in youth
Most treatments for youth depression were first developed 
in the treatment of adults, and subsequently used with young 
people. In contrast to the developmental focus of much 
epidemiologic and neurobiologic research in depression, 
treatment studies have so far rarely directly investigated 
whether developmental factors have predictive or moderat-
ing effects on treatment outcomes. In part this may reflect 
the practical difficulties of conducting therapeutic studies 
with large enough sample sizes to allow robust comparisons 
across developmental periods.
Treatments for preschoolers with depression are currently 
being evaluated (Luby, 2010). We focus here on the three 
main evidence-based treatments for depression in older 
children and adolescents: pharmacotherapy with fluoxetine 
or another serotonin reuptake inhibitor (SRI); cognitive 
and behavioural therapy (CBT); and, interpersonal therapy 
(IPT). Most current evidence concerns the short-term ef-
fects of these treatments as measured in Randomized Con-
trol Trials (RCTs); there is little information at this stage 
about their influence on longer-term outcomes.
Tricyclic antidepressants, while useful in adults, are not 
effective for the treatment of depression in prepubertal 
children, and of dubious effect in adolescents (Hazell, 
O’Connell, Heathcote, & Henry, 2002); the reasons for these 
developmental differences remain poorly understood. By 
contrast, fluoxetine has meta-analytic evidence from RCTs 
for the treatment of depression in both children and ado-
lescents (age range 6-18 years, Hetrick, Merry, McKenzie, 
Sindahl, & Proctor, 2007). Other SRIs have not been shown 
to be consistently effective, although escitalopram was re-
cently approved for the treatment of adolescent depression 
in the United States on the basis of an RCT (Emslie, Ven-
tura, Korotzer, & Tourkodimitris, 2009).
When using SRIs, clinicians should be aware of a series of 
issues. First, the effects of SRIs on youth depression are at 
best moderate, in part because of the high placebo response 
rates in young people (Bridge, Birmaher, Iyengar, Barbe, & 
Brent, 2009). Second, evidence on the effectiveness of SRIs 
is still limited and not without methodological problems, 
such as high rates of attrition. Third, while SRIs may be 
useful for relieving the symptoms of depression, their ef-
fects on other outcomes, including indicators of quality of 
life, are less compelling. Finally, there is an ongoing con-
troversy about how SRIs are related to suicidality in youth, 
with evidence (Hetrick et al., 2007) to suggest that suicidal 
ideation is higher in those treated with fluoxetine compared 
to those treated with placebo in RCTs. However, it is clear 
that the risk of suicidal ideation is far outweighed by the 
benefit conferred by treatment with anti-depressants: the 
number needed to treat for anti-depressants is ten, while 
the number needed to harm with anti-depressants is 143. 
This suggests that there are good reasons to prescribe anti-
depressants in young people while also closely monitoring 
for suicidality along with other side effects (e.g. emergence 
of manic symptoms or agitation).
CBT is also widely recommended for the treatment of de-
pression in children and adolescents. In some countries, 
such as the United Kingdom, it is considered the first line 
treatment for mild depression and an adjunct for moderate 
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to severe depression. However, the meta-analytic evidence 
suggests effects that are in the lower moderate range (less 
than 0.3; Weisz, McCarty, & Valeri, 2006). In the US Treat-
ment of Adolescents with Depression Study (TADS), ado-
lescents receiving CBT did not do better than those on pla-
cebo (March et al., 2004).
Evidence on the effects of combining medication with CBT 
is mixed. In the TADS, combined CBT with fluoxetine led 
to significantly greater improvement than fluoxetine alone. 
Conversely, in the UK Adolescent Depression, Antidepres-
sants and Psychotherapy Trial (ADAPT), there was no ad-
ditional benefit from adding CBT to fluoxetine (Goodyer 
et al., 2007). Perhaps the most compelling evidence comes 
from the Treatment of Resistant Depression in Adolescents 
(TORDIA) study, where switching from fluoxetine to an-
other SRI achieved significantly better response in those 
who also received CBT (Brent et al., 2008).
Finally, several trials suggest that interpersonal therapy 
(IPT) is a useful treatment for depression, with evidence of 
effectiveness in schools (Mufson et al., 2004) and interna-
tional settings (Bolton et al., 2007). At this stage, however, 
the dissemination of IPT remains limited.
Other factors affecting treatment planning will include the 
presence of comorbid disorders and maternal mental health. 
Surprisingly, there is little trial evidence on how to treat co-
morbidity in depression - is it better to treat the depression 
or the comorbid condition or both, and under which circum-
stances? Clinicians usually make case-by-case decisions, 
treating first the condition that is either more chronic or ap-
pears to be the most severe. In relation to maternal mental 
health, evidence suggests that treatment of maternal depres-
sion can help alleviate depression in offspring. Results from 
a trial of mothers with depression treated with medication 
showed that remission of maternal depression was associ-
ated with a significant improvement in children’s depres-
sion, whereas persistence of maternal illness was associated 
with new onset of children’s depression (Weissman et al., 
2006). Finally, clinicians should look out for new technolo-
gies that might enable them to deliver effective treatments 
with relatively little resources. Recent evidence suggests, 
for example, that with adolescents computerized CBT may 
be at least as effective as treatment as usual, including 
face-to-face counseling with clinical psychologists (Merry 
et al., 2012).
Preventing depression using psychological (mainly cogni-
tive and behavioural) techniques seems feasible (Merry et 
al., 2011), although it is likely to be most effective in chil-
dren and adolescents at high risk by virtue of subthresh-
old symptoms, a prior diagnosis of depression, or family 
history. One of the methodologically most rigorous studies 
in this area compared a group-based cognitive and behav-
ioural prevention programme to usual care alone in adoles-
cents at high risk as a result of prior depression or current 
subthreshold symptoms (Garber et al., 2009). The rate of 
incident depression and of self reported depressive symp-
toms was significantly lower in those randomised to the 
prevention arm.
Conclusions
As this brief overview suggests, developmental studies 
have made key contributions to our understanding of child 
and adolescent depression, and the complex interactions be-
tween inherited, psychological and social factors that influ-
ence short- and long-term risk. A developmental perspective 
has been crucial in understanding how distal and proximal 
risks interact with normal developmental processes to affect 
vulnerability for depression in childhood, adolescence and 
adulthood, and in highlighting both similarities and differ-
ences between depressive phenomena arising at these dif-
ferent stages.
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